Tetherex Pharmaceuticals
Dr. Cummings is a co-founder of Selexys. He is the director of the National Center for Functional Glycomics and a Professor in the Department of Surgery at Beth Israel Deaconess Medical Center, Harvard Medical School. Dr. Cummings is a Biochemist and a leader in the emerging field of Glycobiology. Drs. Cummings and McEver co-discovered and characterized PSGL-1 and defined the key carbohydrate determinants necessary for binding P-selectin.
This person is not in the org chart
This person is not in any offices
Tetherex Pharmaceuticals
Tetherex Pharmaceuticals Corporation, located in Oklahoma City, is a privately held clinical-stage development biopharmaceutical company focused on the development of therapeutics for the treatment of inflammation and tumors across a broad range of severe diseases as well as single-cycle adenovirus vaccines for multiple infectious diseases.